# Remifentanil vs. Nicardipine for Controlled Hypotension in Elective Nasal Surgery

> **NCT07660562** · NA · NOT_YET_RECRUITING · sponsor: **Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital** · enrollment: 44 (estimated)

## Conditions studied

- Nasal Surgery
- Anesthesia
- Controlled Hypotension for Nasal Surgeries

## Interventions

- **DRUG:** Nicardipine
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT07660562
- **Lead sponsor:** Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-25
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-07-15
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660562, "Remifentanil vs. Nicardipine for Controlled Hypotension in Elective Nasal Surgery". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07660562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*